Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study

被引：8

作者：

Elman, Lauren ^{[1
]}

Youn, Bora ^{[2
]}

Proud, Crystal M. ^{[3
]}

Frey, Margaret R. ^{[4
]}

Ajroud-Driss, Senda ^{[5
]}

McCormick, M. Eileen ^{[6
]}

Michelson, David ^{[7
]}

Cartwright, Michael S. ^{[8
]}

Heiman-Patterson, Terry ^{[9
]}

Choi, Joseph M. ^{[10
]}

Chandak, Aastha ^{[11
]}

Khachatryan, Artak ^{[12
]}

Martinez, Marta ^{[12
]}

Paradis, Angela D. ^{[2
]}

机构：

[1] Univ Penn, Philadelphia, PA 19104 USA

[2] Biogen, Cambridge, MA USA

[3] Childrens Hosp Kings Daughters, Norfolk, VA USA

[4] Mem Healthcare Inst Neurosci, Owosso, MI USA

[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[6] Oakland Univ, William Beaumont Sch Med, Royal Oak, MI USA

[7] Loma Linda Univ Hlth, Loma Linda, CA USA

[8] Wake Forest Sch Med, Winston Salem, NC 27101 USA

[9] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA

[10] Georgetown Univ Hosp, Washington, DC 20007 USA

[11] Certara, New York, NY USA

[12] Certara, London, England

来源：

JOURNAL OF NEUROMUSCULAR DISEASES | 2022年 / 9卷 / 05期

关键词：

Medication adherence; spinal muscular atrophy; antisense oligonucleotides; neuromuscular diseases; retrospective studies; adults; SHAM CONTROL;

D O I：

10.3233/JND-210768

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Limited evidence exists on real-world adherence to nusinersen for the treatment of spinal muscular atrophy (SMA). Data are presented from a multi-site retrospective chart review of 86 adults with SMA initiating nusinersen at nine US centers between January 2017 and February 2019. Seventy-nine (92%) adults remained on nusinersen during the study; 454 (92%) of 493 total nusinersen doses were received on time. Fifty-eight (67%) adults received all nusinersen doses on time. The majority of patients with at least one nonadherent dose resumed nusinersen on time. Most patients followed the dosing schedule across the loading and maintenance dose periods.

引用

页码：655 / 660

页数：6

共 50 条

[1] Real-World Patterns of Nusinersen Use in Adult Patients with Spinal Muscular Atrophy (SMA) in the US: A Multi-Site Chart Review Study
Elman, Lauren
Youn, Bora
Proud, Crystal M.
Frey, Margaret R.
Ajoud-Driss, Senda
McCormick, Eileen M.
Michelson, David
Cartwright, Michael S.
Heiman-Patterson, Terry
Choi, Joseph M.
Chandak, Aastha
Khachatryan, Artak
Martinez, Marta
Paradis, Angela D.
NEUROLOGY, 2021, 96 (15)
[2] Emerging real-world use of nusinersen in adult patients with spinal muscular atrophy (SMA) in the US: A multi-site chart review study
Paradis, A.
Cochrane, T.
Khachatryan, A.
Martinez, M.
NEUROMUSCULAR DISORDERS, 2020, 30 : S98 - S98
[3] A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3
Cote, Isabelle
Hodgkinson, Victoria
Nury, Marianne
Bastenier-Boutin, Louis
Rodrigue, Xavier
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2025, 52 (01) : 119 - 128
[4] Real-world adherence of nusinersen for the treatment of spinal muscular atrophy (SMA) using US electronic health records
Johnson, Nicole B.
Wang, Nasha
Youn, Bora
Paradis, Angela D.
Viscidi, Emma
Eaton, Susan
Hall, Sue
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 321 - 321
[5] Real-world Outcomes of Onasemnogene Abeparvovec Alone or with Prior Nusinersen in Pediatric Patients with Spinal Muscular Atrophy: Interim Analysis of a US Chart Review Study
Dabbous, O.
Yang, M.
Georgieva, M.
Toro, W.
LaMarca, N.
Patel, A.
Minkoff, N.
Carley, C.
Zhu, J.
Anderson, A.
Wu, E.
ANNALS OF NEUROLOGY, 2021, 90 : S153 - S153
[6] REAL-WORLD ADHERENCE OF NUSINERSEN FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA) USING US LARGE ADMINISTRATIVE CLAIMS DATASET
Johnson, N.
Hou, Q.
Paradis, A. D.
Proud, C.
Youn, B.
VALUE IN HEALTH, 2022, 25 (01) : S226 - S226
[7] Examining Real-World Adherence to Nusinersen for the Treatment of Spinal Muscular Atrophy Using Two Large US Data Sources
Youn, Bora
Proud, Crystal M.
Wang, Nasha
Hou, Qiang
Viscidi, Emma
Eaton, Susan
Paradis, Angela D.
Neville, Bridget A.
Johnson, Nicole B.
ADVANCES IN THERAPY, 2023, 40 (03) : 1129 - 1140
[8] Examining Real-World Adherence to Nusinersen for the Treatment of Spinal Muscular Atrophy Using Two Large US Data Sources
Bora Youn
Crystal M. Proud
Nasha Wang
Qiang Hou
Emma Viscidi
Susan Eaton
Angela D. Paradis
Bridget A. Neville
Nicole B. Johnson
Advances in Therapy, 2023, 40 : 1129 - 1140
[9] Real-world Outcomes of Nusinersen Alone and Onasemnogene Abeparvovec (OA) Alone or with Prior Nusinersen in Pediatric Patients with Spinal Muscular Atrophy (SMA): Interim Analysis of a US Retrospective Chart Review Study
Dabbous, Omar
Yang, Min
Georgieva, Mihaela
Jimenez, Walter Toro
LaMarca, Nicole
Patel, Anish
Carley, Christopher
Reyna, Sandra
NEUROLOGY, 2022, 98 (18)
[10] Nusinersen in children and adults with spinal muscular atrophy in Argentina: Real world experienc
Dubrovsky, A.
Mesa, L.
Corderi, J.
Flores, D.
Morosini, M.
Bolano, C.
Jauregui, A.
Pirra, L.
Vazquez, G.
Chloca, F.
NEUROMUSCULAR DISORDERS, 2022, 32 : S88 - S89

← 1 2 3 4 5 →